Accelerant Holdings (ARX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The consensus price target hints at a 34.4% upside potential for Accelerant Holdings (ARX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The mean of analysts' price targets for Accelerant Holdings (ARX) points to a 38.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Accelerant Holdings (ARX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The mean of analysts' price targets for Accelerant Holdings (ARX) points to a 51.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The headline numbers for Accelerant Holdings (ARX) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Accelerant's specialty insurance exchange is scaling, connecting underwriters with risk capital. ARX shares look undervalued versus earnings power, even assuming little near-term growth. The hybrid model adds complexity, but fees plus selective risk retention can drive profits.
Accelerant Holdings (ARX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The headline numbers for Accelerant Holdings (ARX) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Accelerant (ARX) debuted on the NYSE with a 36% surge, but shares have since fallen 38% below the IPO price. ARX positions itself as a 'data driven risk exchange,' aiming to transform the specialty insurance market through technology and innovative business models. The article explores whether ARX's current valuation presents a bargain opportunity or if the stock's decline signals deeper concerns.
Accelerant Holdings (NYSE:ARX ) Q2 2025 Earnings Conference Call August 28, 2025 8:00 AM ET Company Participants Jay Michael Green - Chief Financial Officer Jeffrey Lee Radke - Co-Founder, CEO & Director Ryan Schiller - Corporate Participant Conference Call Participants Andrew Scott Kligerman - TD Cowen, Research Division Charles Gregory Peters - Raymond James & Associates, Inc., Research Division Charles William Lederer - BMO Capital Markets Equity Research Hristian Getsov - Wells Fargo Securities, LLC, Research Division Jon Paul Newsome - Piper Sandler & Co., Research Division Matthew Casey O'Neill - Unidentified Company Financial Technology Partners LP - Unidentified Company Robert Cox - Goldman Sachs Group, Inc., Research Division Operator Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today.